China Facial Injectable Market Size & Outlook, 2023-2030
China facial injectable market, 2018-2030 (US$M)
Related Markets
China facial injectable market highlights
- The China facial injectable market generated a revenue of USD 268.3 million in 2023 and is expected to reach USD 552.3 million by 2030.
- The China market is expected to grow at a CAGR of 10.9% from 2024 to 2030.
- In terms of segment, botulinum toxin type a was the largest revenue generating product in 2023.
- HA is the most lucrative product segment registering the fastest growth during the forecast period.
Facial injectable market data book summary
| Market revenue in 2023 | USD 268.3 million |
| Market revenue in 2030 | USD 552.3 million |
| Growth rate | 10.9% (CAGR from 2023 to 2030) |
| Largest segment | Botulinum toxin type a |
| Fastest growing segment | HA |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Collagen, Botulinum Toxin Type A, HA, CaHA, Polymer Fillers |
| Key market players worldwide | Ipsen SA, AbbVie Inc, Medytox, Revance Therapeutics Inc, Galderma Group AG Registered Shares, Sinclair Pharma plc, Merz Pharma |
Other key industry trends
- In terms of revenue, China accounted for 2.3% of the global facial injectable market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, South Korea facial injectable market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 629.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Facial Injectable Market Scope
Facial Injectable Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China facial injectable market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to facial injectable market will help companies and investors design strategic landscapes.
Botulinum toxin type a was the largest segment with a revenue share of 55.5% in 2023. Horizon Databook has segmented the China facial injectable market based on collagen, botulinum toxin type a, ha, caha, polymer fillers covering the revenue growth of each sub-segment from 2018 to 2030.
According to a report by Gengmei in 2019, nearly 25 million cosmetic surgeries were performed in China. In addition, the average age of patients declined to 24 years in 2019, and approximately 38% of the patients were aged between 20 and 25.
The increasing number of procedures in the young population highlights the high demand for such procedures. Moreover, the presence of major players is driving the market. For instance, Bloomage Biotechnology, which is one of the world’s largest producers of HA-based dermal fillers, is headquartered in China, which drives innovations & product acceptability, thereby contributing to market growth.
Furthermore, in June 2023, Bloomage Biotech announced a project to construct an ecosystem focused on HA production. Consequently, Bloomage Biotech and Jinan High-tech Zone will jointly develop the project, and the former firm will contribute USD 37 billion to the project.
Reasons to subscribe to China facial injectable market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China facial injectable market databook
-
Our clientele includes a mix of facial injectable market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China facial injectable market , including forecasts for subscribers. This country databook contains high-level insights into China facial injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China facial injectable market size, by product, 2018-2030 (US$M)
China Facial Injectable Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
